Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Inhibitors of α-glucosidase and Angiotensin-converting Enzyme in the Treatment of Type 2 Diabetes and its Complications: A Review on in Silico Approach

2022Pharmaceutical and Biomedical ResearchJournalOpen access

10.32598/pbr.8.4.1052.1 Full text3 citations

Authors

6 authors across 2 institutions in 1 country.

Oyedele Abdul-Quddus KehindeFirst author
- Ladoke Akintola University of Technology (NG)
Boyenle Ibrahim Damilare
- Ladoke Akintola University of Technology (NG)
AbdeenTunde Ogunlana
- Ladoke Akintola University of Technology (NG)
Ashiru Mojeed Ayoola
- Fountain University (NG)
Atanda Opeyemi Emmanuel
- Ladoke Akintola University of Technology (NG)
Adelusi Temitope IsaacSenior author
- Ladoke Akintola University of Technology (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Natural Antidiabetic Agents Studieslevel 3 · 0.99
Computational Drug Discovery Methodslevel 3 · 0.99
Nutrition, Genetics, and Diseaselevel 3 · 0.96

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2022 · Pharmaceutical and Biomedical Research · 3 citations
https://openalex.org/W4367157441

Inhibitors of α-glucosidase and Angiotensin-converting Enzyme in the Treatment of Type 2 Diabetes and its Complications: A Review on in Silico Approach · Sankore